Modified-release dosage
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage).
Mechanism of action[edit]
Modified-release dosage systems have a number of advantages over traditional dosage forms. They can reduce the frequency of dosing, improve patient compliance, and maintain steady drug plasma levels. This is achieved by controlling the rate, time, and place of release of drugs in the body.
Types of modified-release dosage[edit]
There are several types of modified-release dosage, including delayed-release dosage, extended-release dosage, and targeted-release dosage.
- Delayed-release dosage involves delaying the release of the medication until it has passed through the stomach to avoid the drug being destroyed or inactivated by stomach acids.
- Extended-release dosage involves the drug being released over an extended period, allowing for a reduction in frequency of dosing.
- Targeted-release dosage involves the drug being released at a specific target in the body, improving the efficacy of the drug and reducing side effects.
Applications[edit]
Modified-release dosage forms are used in a number of therapeutic areas, including the treatment of chronic conditions such as diabetes, hypertension, and neurological disorders. They are also used in the treatment of pain, where sustained release of medication can provide better pain control.
Challenges[edit]
Despite the advantages, there are also challenges associated with the use of modified-release dosage forms. These include the complexity of drug formulation, the need for patient education to ensure correct use, and the potential for variable bioavailability.
See also[edit]
References[edit]
<references />
-
Concerta 54mg OROS tablet
-
Split Bupropion XL shell by Anchen
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
